It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Understanding gender-associated bias in aging and obesity-driven metabolic derangements has been hindered by the inability to model severe obesity in female mice.
Methods
Here, using chow- or high fat diet (HFD)-feeding regimens at standard (TS) and thermoneutral (TN) housing temperatures, the latter to model obesity in female mice, we examined the impact of gender and aging on obesity-associated metabolic derangements and immune responsiveness. Analysis included quantification of: (i) weight gain and adiposity; (ii) the development and severity of glucose dysmetabolism and non-alcoholic fatty liver disease (NAFLD); and (iii) induction of inflammatory pathways related to metabolic dysfunction.
Results
We show that under chow diet feeding regimen, aging was accompanied by increased body weight and white adipose tissue (WAT) expansion in a gender independent manner. HFD feeding regimen in aged, compared to young, male mice at TS, resulted in attenuated glucose dysmetabolism and hepatic steatosis. However, under TS housing conditions only aged, but not young, HFD fed female mice developed obesity. At TN however, both young and aged HFD fed female mice developed severe obesity. Independent of gender or housing conditions, aging attenuated the severity of metabolic derangements in HFD-fed obese mice. Tempered severity of metabolic derangements in aged mice was associated with increased splenic frequency of regulatory T (Treg) cells, Type I regulatory (Tr1)-like cells and circulating IL-10 levels and decreased vigor of HFD-driven induction of inflammatory pathways in adipose and liver tissues.
Conclusion
Our findings suggest that aging-associated altered immunological profile and inflammatory vigor may play a dominant role in the attenuation of obesogenic diet-driven metabolic dysfunction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Division of Immunobiology Cincinnati Children’s Hospital Medical Center, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
2 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Division of Immunobiology Cincinnati Children’s Hospital Medical Center, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Immunology Graduate Program Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593)
3 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Division of Immunobiology Cincinnati Children’s Hospital Medical Center, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Immunology Graduate Program Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Center for Transplant Immunology, and Inflammation and Tolerance, Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)
4 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Division of Immunobiology Cincinnati Children’s Hospital Medical Center, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Immunology Graduate Program Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Center for Inflammation and Tolerance, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099)